Integra Therapeutics’ €4.5 Million Financing Round

Cuatrecasas advised Invivo Capital, Advent Biotechnology and Takeda Ventures on the round of financing in Integra Therapeutics.At closure of the transaction, the spin-off of Universitat Pompeu…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now